Bill

Bill > S95


US S95

US S95
SAVE Moms and Babies Act of 2023 Support And Value Expectant Moms and Babies Act of 2023


summary

Introduced
01/26/2023
In Committee
01/26/2023
Crossed Over
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

AI Summary

This bill, the Support And Value Expectant Moms and Babies Act of 2023 (SAVE Moms and Babies Act of 2023), aims to prohibit the approval of new abortion drugs and the use of investigational exemptions for such drugs. It also imposes additional regulatory requirements on previously approved abortion drugs, including restrictions on their labeling and dispensing. The bill defines "abortion drug" and "adverse event", and requires health care practitioners who prescribe abortion drugs to meet certain certification criteria and report any associated deaths or adverse events. It also requires all other health care practitioners to report any adverse events connected to the use of abortion drugs. The bill preserves the authority of the federal government and states to establish additional requirements and restrictions on abortion drugs.

Committee Categories

Health and Social Services

Sponsors (33)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 01/26/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...